By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Biovista today announced its European Union affiliate has been awarded a $500,000 grant to apply its technology to an EU project in personalized medicine.

The grant will be used by the firm to apply the multi-dimensional profiling capabilities of its Clinical Outcomes Search Space platform to identify new treatments "that reflect patients' individual pathophysiological characteristics," it said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: association between genome-wide homozygosity and traits like height and cognitive ability, improved CRISPR-Cas9 editing, and more.

A survey examines how age, political leanings, and more influence how Americans view certain scientific topics, the Associated Press reports.

A researcher who pleaded guilty to making false statements in research reports has been sentenced to four and a half years in prison and must pay $7.2 million back to the NIH.

The BabySeq project to study the risks and benefits of sequencing newborns is underway.